Last reviewed · How we verify
triamcinolone in orabase
At a glance
| Generic name | triamcinolone in orabase |
|---|---|
| Also known as | kenacorte |
| Sponsor | Mona Taha Mohammed MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment (NA)
- Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus (PHASE2)
- Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment (PHASE2, PHASE3)
- EVR and EPO for Liver Transplant Tolerance (PHASE1)
- Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant (PHASE4)
- Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers (PHASE2, PHASE3)
- Evaluation of Efficacy of Neem (Azadirachta Indica) Versus Triamcinolone Acetonide in the Treatment of Oral Lichen Planus. (PHASE1, PHASE2)
- Efficacy of Coconut Gel Compared to Corticosteroid Gel in the Management of Oral Lichen Planus (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- triamcinolone in orabase CI brief — competitive landscape report
- triamcinolone in orabase updates RSS · CI watch RSS
- Mona Taha Mohammed MD portfolio CI